Affordability

Smarter Affordability.
More Direct Access.
Better Outcomes.

Affordability is no longer just financial assistance. It is a strategic access and commercialization advantage.​

EVERSANA helps life sciences companies transform affordability into a powerful driver of patient access, therapy adoption, and Gross-to-Net performance. By connecting intelligent copay design, marketplace-style adjudication, direct access pathways, patient services, and actionable analytics, we help manufacturers reduce friction, improve visibility, and create better outcomes for patients and brands.

Talk to an Affordability Expert​​​

Connecting Access, Affordability and Outcomes

Connecting intelligent affordability, direct access pathways and patient-first support to improve access, accelerate time to therapy and drive better outcomes.

Affordability That Works Smarter​

Optimize affordability investments without compromising patient access.

  • Maximize affordability investment impact with intelligent copay strategies
  • Gain transparency and control through marketplace-style adjudication
  • Improve Gross-to-Net performance with advanced analytics and safeguards
Explore Intelligent Copay Solutions

Access That Feels More Direct​

Affordability is most effective when it is integrated into the broader access journey.

  • Affordability embedded within a connected access pathway
  • Reduced friction between prescription, fulfillment and therapy initiation
  • EVERSANA DIRECT capabilities that help simplify and accelerate patient access
Explore EVERSANA DIRECT

Patient-First Outcomes at Scale​

Every affordability solution should support what matters most: helping the right patient start and stay on the right therapy.

  • Integrated affordability, patient services and digital engagement
  • Faster therapy starts and stronger adherence over time
  • Data-driven insights that improve outcomes and program effectiveness
Explore Patient Support Solutions

Overcome Financial Barriers to Drive Better Outcomes

Transform Affordability Into a Smarter Access Strategy

For millions of patients, the rising cost of care is a barrier to essential treatment, hindering access, adherence, and outcomes. With half of U.S. adults struggling to afford care, it’s clear that healthcare affordability needs a systemic shift.

To address this growing challenge, manufacturers need innovative affordability programs that combine real-time patient data with personalized financial support.

The Affordability Crisis Is an Access Crisis

  • 25%
    skip or delay healthcare due to cost
  • 10%
    cut pills or skip doses to save money
  • 61%
    of uninsured adults go without care due to cost
  • 37%
    don't fill prescriptions due to cost
  • 74%
    worry about affording unexpected medical bills
  • 50%
    of U.S. adults find healthcare costs difficult to afford

Meet EVERSANA's Copay and Patient Assistance Programs

Scalable solutions that support patients from financial assistance to ongoing care—driving therapy adoption and improving outcomes.

Co-Pay Programs

Alleviate Patients’ Financial Burdens

Learn More

Patient Assistance Programs

Deliver Customized Affordability Offers

Learn More

Talk to an Affordability Expert

Frequently Asked Questions

What is marketplace-style adjudication?

Marketplace-style adjudication provides greater flexibility, transparency and control by introducing a more intelligent approach to routing and managing affordability claims.

Why does affordability need to evolve?

Manufacturers are under pressure to improve access, manage affordability costs, protect Gross-to-Net performance and demonstrate program effectiveness. Traditional affordability programs often operate in silos. EVERSANA takes a more connected approach, integrating affordability into the broader patient access journey to deliver smarter decisions, stronger visibility and better outcomes.

How can pharmaceutical manufacturers optimize copay spending?

By combining intelligent copay design, analytics, program oversight and marketplace-style adjudication, manufacturers can improve affordability program efficiency while preserving patient access.

How does affordability impact Gross-to-Net performance?

Affordability programs represent a significant investment for manufacturers. The right strategy can help improve visibility, optimize spending and better align patient support with commercialization goals.

What role does affordability play in patient access?

Affordability helps remove financial barriers that can delay or prevent treatment initiation, making it a critical component of the overall patient access journey.

How does EVERSANA DIRECT support affordability programs?

EVERSANA DIRECT integrates affordability into a broader access ecosystem, helping connect patients to therapy faster while reducing friction across the treatment journey.